316 related articles for article (PubMed ID: 14613958)
1. Phage lytic enzymes as therapy for antibiotic-resistant Streptococcus pneumoniae infection in a murine sepsis model.
Jado I; López R; García E; Fenoll A; Casal J; García P;
J Antimicrob Chemother; 2003 Dec; 52(6):967-73. PubMed ID: 14613958
[TBL] [Abstract][Full Text] [Related]
2. In vitro interactions of LytA, the major pneumococcal autolysin, with two bacteriophage lytic enzymes (Cpl-1 and Pal), cefotaxime and moxifloxacin against antibiotic-susceptible and -resistant Streptococcus pneumoniae strains.
Rodríguez-Cerrato V; García P; Del Prado G; García E; Gracia M; Huelves L; Ponte C; López R; Soriano F
J Antimicrob Chemother; 2007 Nov; 60(5):1159-62. PubMed ID: 17827138
[TBL] [Abstract][Full Text] [Related]
3. A novel chimeric phage lysin with high in vitro and in vivo bactericidal activity against Streptococcus pneumoniae.
Díez-Martínez R; De Paz HD; García-Fernández E; Bustamante N; Euler CW; Fischetti VA; Menendez M; García P
J Antimicrob Chemother; 2015; 70(6):1763-73. PubMed ID: 25733585
[TBL] [Abstract][Full Text] [Related]
4. Bactericidal synergism between daptomycin and the phage lysin Cpl-1 in a mouse model of pneumococcal bacteraemia.
Vouillamoz J; Entenza JM; Giddey M; Fischetti VA; Moreillon P; Resch G
Int J Antimicrob Agents; 2013 Nov; 42(5):416-21. PubMed ID: 23992647
[TBL] [Abstract][Full Text] [Related]
5. Pneumococcal LytA autolysin, a potent therapeutic agent in experimental peritonitis-sepsis caused by highly beta-lactam-resistant Streptococcus pneumoniae.
Rodríguez-Cerrato V; García P; Huelves L; García E; Del Prado G; Gracia M; Ponte C; López R; Soriano F
Antimicrob Agents Chemother; 2007 Sep; 51(9):3371-3. PubMed ID: 17576844
[TBL] [Abstract][Full Text] [Related]
6. Phage lytic enzyme Cpl-1 for antibacterial therapy in experimental pneumococcal meningitis.
Grandgirard D; Loeffler JM; Fischetti VA; Leib SL
J Infect Dis; 2008 Jun; 197(11):1519-22. PubMed ID: 18471063
[TBL] [Abstract][Full Text] [Related]
7. Phage lytic enzyme Cpl-1 as a novel antimicrobial for pneumococcal bacteremia.
Loeffler JM; Djurkovic S; Fischetti VA
Infect Immun; 2003 Nov; 71(11):6199-204. PubMed ID: 14573637
[TBL] [Abstract][Full Text] [Related]
8. Bacteriophage in the treatment of experimental septicemic mice from a clinical isolate of multidrug resistant Klebsiella pneumoniae.
Vinodkumar CS; Neelagund YF; Kalsurmath S
J Commun Dis; 2005 Mar; 37(1):18-29. PubMed ID: 16637396
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy with Phage Lysins Reduces Pneumococcal Colonization of the Respiratory Tract.
Corsini B; Díez-Martínez R; Aguinagalde L; González-Camacho F; García-Fernández E; Letrado P; García P; Yuste J
Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29581113
[TBL] [Abstract][Full Text] [Related]
10. Bactericidal synergism between antibiotics and phage endolysin Cpl-711 to kill multidrug-resistant pneumococcus.
Letrado P; Corsini B; Díez-Martínez R; Bustamante N; Yuste JE; García P
Future Microbiol; 2018 Sep; 13(11):1215-1223. PubMed ID: 30238774
[TBL] [Abstract][Full Text] [Related]
11. Rapid killing of Streptococcus pneumoniae with a bacteriophage cell wall hydrolase.
Loeffler JM; Nelson D; Fischetti VA
Science; 2001 Dec; 294(5549):2170-2. PubMed ID: 11739958
[TBL] [Abstract][Full Text] [Related]
12. Systemic use of the endolysin Cpl-1 rescues mice with fatal pneumococcal pneumonia.
Witzenrath M; Schmeck B; Doehn JM; Tschernig T; Zahlten J; Loeffler JM; Zemlin M; Müller H; Gutbier B; Schütte H; Hippenstiel S; Fischetti VA; Suttorp N; Rosseau S
Crit Care Med; 2009 Feb; 37(2):642-9. PubMed ID: 19114881
[TBL] [Abstract][Full Text] [Related]
13. Taking aim on bacterial pathogens: from phage therapy to enzybiotics.
Hermoso JA; García JL; García P
Curr Opin Microbiol; 2007 Oct; 10(5):461-72. PubMed ID: 17904412
[TBL] [Abstract][Full Text] [Related]
14. High-yield production of a functional bacteriophage lysin with antipneumococcal activity using a plant virus-based expression system.
Starkevič U; Bortesi L; Virgailis M; Ružauskas M; Giritch A; Ražanskienė A
J Biotechnol; 2015 Apr; 200():10-6. PubMed ID: 25744664
[TBL] [Abstract][Full Text] [Related]
15. Effect of high dose oral zinc in mice with severe infection with Streptococcus pneumoniae.
Hembre BS; Briles DE; Grewal HM; Strand TA
Scand J Infect Dis; 2008; 40(5):363-7. PubMed ID: 17963160
[TBL] [Abstract][Full Text] [Related]
16. Bacteriophage lytic enzymes: novel anti-infectives.
Fischetti VA
Trends Microbiol; 2005 Oct; 13(10):491-6. PubMed ID: 16125935
[TBL] [Abstract][Full Text] [Related]
17. RNAIII-inhibiting peptide improves efficacy of clinically used antibiotics in a murine model of staphylococcal sepsis.
Giacometti A; Cirioni O; Ghiselli R; Dell'Acqua G; Orlando F; D'Amato G; Mocchegiani F; Silvestri C; Del Prete MS; Rocchi M; Balaban N; Saba V; Scalise G
Peptides; 2005 Feb; 26(2):169-75. PubMed ID: 15629527
[TBL] [Abstract][Full Text] [Related]
18. Albomycin is an effective antibiotic, as exemplified with Yersinia enterocolitica and Streptococcus pneumoniae.
Pramanik A; Stroeher UH; Krejci J; Standish AJ; Bohn E; Paton JC; Autenrieth IB; Braun V
Int J Med Microbiol; 2007 Oct; 297(6):459-69. PubMed ID: 17459767
[TBL] [Abstract][Full Text] [Related]
19. Use of bacteriophage in the treatment of experimental animal bacteremia from imipenem-resistant Pseudomonas aeruginosa.
Wang J; Hu B; Xu M; Yan Q; Liu S; Zhu X; Sun Z; Reed E; Ding L; Gong J; Li QQ; Hu J
Int J Mol Med; 2006 Feb; 17(2):309-17. PubMed ID: 16391831
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic effects of bacteriophage Cpl-1 lysin against Streptococcus pneumoniae endocarditis in rats.
Entenza JM; Loeffler JM; Grandgirard D; Fischetti VA; Moreillon P
Antimicrob Agents Chemother; 2005 Nov; 49(11):4789-92. PubMed ID: 16251333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
